Revolution Medicines officer Mancini sells $743k in stock
Anthony Mancini, Chief Global Commercialization Officer at Revolution Medicines, Inc., sold $743,285 worth of company stock on September 24-25, 2026. The sale complied with a pre-set 10b5-1 trading plan approved on June 11, 2026. In total, he disposed of 3,121 shares, purchased 3,121 shares, and owns 39,765 shares of Revolution Medicines stock.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
